Genomics and Clinical Integration · Healthcare Performance Intelligence
Genomics and Clinical Data Integration Without Losing Context
Bring qualified genomic outputs beside the phenotype and history required to interpret them—without becoming a sequencing pipeline.
See What Vizier Finds in Your DataBring the data you already collect. Keep the systems that produce it.
The buyer problem
More data has made interpretation harder for genomics laboratories and precision-health programmes.
Genomic findings often arrive as static documents while phenotype evolves across EHRs, labs and programme systems. The integration challenge is semantic and evidentiary, not merely technical.
The answer is not another isolated dashboard. It is a governed way to evaluate change across time and modalities, preserve what each source can and cannot establish, and make the underlying evidence available for review.
Where interpretation breaks
- Patient and sample identifiers mismatch
- Phenotype is incomplete or stale
- Classification date is lost
- Risk is presented without population limitations
Data landscape
The signals involved
The job is not to force unlike data into one score. It is to preserve provenance, time, context and uncertainty while making the relationships investigable.
Genomic findings
Interpreted variants, pharmacogenomic and risk outputs from qualified sources.
Structured phenotype
Conditions, family history, observations and relevant negative findings.
Medication context
Current and historical therapies needed for pharmacogenomic review.
Evidence metadata
Source, classification, version, population and review date.
The intelligence layer
What Vizier adds
Unified review context
Place genomic findings beside current phenotype and treatment history.
Re-review cues
Identify findings whose evidence date or phenotype context has changed.
Contradiction visibility
Show when observed phenotype does not support a presumed expression.
Governed handoff
Keep specialist interpretation and approval in the workflow.
Interpretation discipline
Evidence before certainty
Vizier should make complex data easier to investigate without making the evidence stronger than it is. A temporal relationship is not automatically causal. A genetic association is not a diagnosis. Movement in a surrogate biomarker is not necessarily a clinical outcome.
Findings should retain source, timing, reference context and confidence. Where modalities disagree, data is missing, or follow-up is too short, the useful answer is often that the evidence is insufficient.
The distinctions that matter
- Association is not causality; timing and confounding still matter.
- Genetic predisposition is not the same as expressed phenotype.
- Biomarker movement is not automatically a clinical outcome.
- A biological-age estimate is model output, not a lifespan prediction.
Clear product boundary
What Vizier does—and does not—replace
Vizier integrates and analyses qualified outputs. It does not process raw reads, call variants or issue clinical genetic diagnoses.
Vizier consumes authorised outputs from the systems you choose. Source access, format, identity matching, governance, hosting and clinical review responsibilities are confirmed during discovery.
Vizier is not
- A sequencing or FASTQ/BAM/VCF processing pipeline
- A laboratory, EHR, scheduling, billing or CRM system
- A diagnostic device or autonomous clinical decision-maker
- A claim that an intervention caused a later change
Workflow
From fragmented outputs to a reviewable investigation
01
Inventory authorised sources, identifiers, time semantics and decision questions.
02
Validate units, mappings, provenance, missingness and clinically relevant comparison periods.
03
Configure longitudinal and cross-signal investigations around the organisation's reviewed definitions.
04
Return findings with evidence, uncertainty and a traceable path back to source data.
Questions buyers ask
Frequently asked questions
What is genomics and clinical integration?
Genomics and Clinical Integration is the governed analysis of relevant health data for longitudinal and cross-signal questions. For Vizier, that means analysing authorised outputs while retaining provenance, time and uncertainty.
Does Vizier replace our existing clinical or diagnostic systems?
Vizier integrates and analyses qualified outputs. It does not process raw reads, call variants or issue clinical genetic diagnoses.
Can Vizier prove that an intervention caused a change?
Not from timing alone. Vizier can align observations to an intervention, show competing explanations and describe the strength of evidence. Causal claims require an appropriate design and expert review.
How does implementation start?
With one decision question and a source inventory. Vizier validates access, identifiers, units, time semantics, governance and the review workflow before a capability is represented as production-ready.
See genomics and clinical integration across the data you already collect.
Bring the data you already collect. See what Vizier finds across it.
Start with the data you already have. Connect your EHR when you’re ready.